Manama: Two of the world’s leading geneticists will discuss the advancements of stem cell therapy in Doha this month during the Qatar Foundation Annual Research Conference (ARC’13), organised by Qatar Foundation Research and Development (QF R&D) and its research institutes.
Sir Martin John Evans, an advisory board member of Qatar Biomedical Research Institute (QBRI), and Professor Shinya Yamanaka, Director of the Centre for iPS Cell Research and Application at Kyoto University, were each awarded the Nobel Prize in Physiology or Medicine, in 2007 and 2012, respectively, for their breakthrough research in stem cells.
Professor Yamanak, who received the award for discovering how to re-programme mature cells to become pluripotent, will take part in a panel discussion titled ‘Facing the Challenges - International Experiences and Qatar’s Opportunities’, during the opening plenary of this year’s Annual Research Conference.
Both Professor Yamanaka and Sir Martin Evans, who was awarded the Nobel Prize for his contributions towards the discovery of principles for the introduction of specific gene modifications in mice through the use of embryonic stem cells, will participate in a debate titled ‘Stem Cells and Gene Therapies: Promises and Challenges’ on the second day of the conference to be held on November 24-25.
Qatar Biomedical Research Institute is a principal constituent of Qatar Foundation Research and Development and will lead these discussions, and other health deliberations, at the conference.
Genomic medicine
“The number of international, regional and local leading experts taking part in the Annual Research Conference will once again shed light on Qatar’s thriving research landscape and showcase the activities of top scientists here in Qatar,” Abdul Ali Haoudi, Executive Director of QBRI, said. “Our institute was established to tackle diseases such as diabetes and cancer through five research laboratories and two research centres, including the Stem Cell and Regenerative Medicine Research Centre.”
At the conference QBRI will showcase its latest developments in genomic medicine and stem cell research with regard to diabetes.
According to the International Diabetes Federation, Qatar has a high prevalence of the disease ranking eighth globally with a 23.3 per cent comparative prevalence rate.
Dr Philippe Froguel, QBRI’s Scientific Director of Genomic Medicine and Systems Biology Research Centre, will present his latest findings at the conference showing the genetic basis of diabetes as well as the link between type 2 diabetes patients and their predisposition to develop certain kinds of cancer. Dr Froguel’s findings were recently published in international scientific journals, including Nature Genetics, and he was the first person in the world to identify the type 2 diabetes gene.
The conference will serve as a platform in which various other research grand challenges will be highlighted. These include the protection of Qatar’s cyber infrastructure, supporting the preservation of Arabic culture, art, language and heritage, as well as ensuring sustainable food supply.
Other Qatar Foundation Research and Development constituents, including Qatar Computing Research Institute (QCRI), Qatar Energy and Environment Research Institute (QEERI), Qatar Science & Technology Park (QSTP) and Qatar National Research Fund (QNRF) will be among the entities to address how best to tackle such challenges. The Annual Research Conference will inform national stakeholders, local organisations and international partners about Qatar’s latest research initiatives through networking sessions that will help facilitate knowledge transfer.
